Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FINEGOLD M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Oka, K; Pastore, L; Kim, IH; Merched, A; Nomura, S; Lee, HJ; Merched-Sauvage, M; Arden-Riley, C; Lee, B; Finegold, M; Beaudet, A; Chan, L
      Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor

      CIRCULATION
    2. Wang, X; Al-Dhalimy, M; Lagasse, E; Finegold, M; Grompe, M
      Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells

      AMERICAN JOURNAL OF PATHOLOGY
    3. Lagasse, E; Connors, H; Al-Dhalimy, M; Reitsma, M; Dohse, M; Osborne, L; Wang, X; Finegold, M; Weissman, IL; Grompe, M
      Purified hematopoietic stem cells can differentiate into hepatocytes in vivo

      NATURE MEDICINE
    4. Stepanova, L; Yang, G; DeMayo, F; Wheeler, TM; Finegold, M; Thompson, TC; Harper, JW
      Induction of human Cdc37 in prostate cancer correlates with the ability oftargeted Cdc37 expression to promote prostatic hyperplasia

      ONCOGENE
    5. Block, A; Freund, CTF; Chen, SH; Nguyen, KP; Finegold, M; Windler, E; Woo, SLC
      Gene therapy of metastatic colon carcinoma: Regression of multiple hepaticmetastases by adenoviral expression of bacterial cytosine deaminase

      CANCER GENE THERAPY
    6. Stepanova, L; Finegold, M; DeMayo, F; Schmidt, EV; Harper, JW
      The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues

      MOLECULAR AND CELLULAR BIOLOGY
    7. Zhao, BH; Magdaleno, S; Chua, S; Wang, YL; Burcin, M; Elberg, D; Finegold, M; Tsai, S; DeMayo, FJ
      Transgenic mouse models for lung cancer

      EXPERIMENTAL LUNG RESEARCH
    8. Zhang, PM; Wong, C; Liu, D; Finegold, M; Harper, JW; Elledge, SJ
      p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step

      GENES & DEVELOPMENT
    9. Manning, K; Al-Dhalimy, M; Finegold, M; Grompe, M
      In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Vogel, H; Lim, DS; Karsenty, G; Finegold, M; Hasty, P
      Deletion of Ku86 causes early onset of senescence in mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Herman, GE; Finegold, M; Zhao, W; de Gouyon, B; Metzenberg, A
      Medical complications in long-term survivors with X-linked myotubular myopathy

      JOURNAL OF PEDIATRICS
    12. Harriman, GR; Bogue, M; Rogers, P; Finegold, M; Pacheco, S; Bradley, A; Zhang, YX; Mbawuike, IN
      Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other ig isotypes

      JOURNAL OF IMMUNOLOGY
    13. Overturf, K; Al-Dhalimy, M; Finegold, M; Grompe, M
      The repopulation potential of hepatocyte populations differing in size andprior mitotic expansion

      AMERICAN JOURNAL OF PATHOLOGY
    14. OVERTURF K; ALDHALIMY M; MANNING K; OU CN; FINEGOLD M; GROMPE M
      EX-VIVO HEPATIC GENE-THERAPY OF A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Human gene therapy
    15. BROADDUS R; DINH M; FINEGOLD M
      FLOW CYTOMETRIC DNA ANALYSIS OF COLONIC MUCOSA FROM G-ALPHA(12)-DEFICIENT MICE

      The FASEB journal
    16. FINEGOLD M; SCHWARTZ M; BROADDUS R
      RETINOBLASTOMA PROTEIN EXPRESSION AND PROLIFERATION IN HYPERPLASTIC POLYPS, ADENOMAS, AND COLONIC ADENOCARCINOMAS

      The FASEB journal
    17. GROMPE M; OVERTURF K; ALDHALIMY M; FINEGOLD M
      THERAPEUTIC TRIALS IN THE MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I - A PROGRESS REPORT

      Journal of inherited metabolic disease
    18. OVERTURF K; ALDHALIMY M; OU CN; FINEGOLD M; TANGUAY R; LIEBER A; KAY M; GROMPE M
      ADENOVIRUS-MEDIATED GENE-THERAPY IN A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Human gene therapy
    19. OVERTURF K; ALDHALIMY M; FINEGOLD M; GROMPE M
      SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTE

      The FASEB journal
    20. BROADDUS R; BROOKS T; FINEGOLD M
      TGF-BETA EXPRESSION AND BASEMENT-MEMBRANE DEGRADATION IN COLITIS-ASSOCIATED DYSPLASIAS AND ADENOCARCINOMAS IN G-ALPHA(12)-DEFICIENT MICE

      The FASEB journal
    21. BLOCK A; CHEN SH; KOSAI KI; FINEGOLD M; WOO SLC
      ADENOVIRAL-MEDIATED HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE-TRANSFER - REGRESSION OF HEPATIC METASTASIS OF PANCREATIC TUMORS

      Pancreas
    22. ZHANG PM; LIEGEOIS NJ; WONG C; FINEGOLD M; HOU H; THOMPSON JC; SILVERMAN A; HARPER JW; DEPINHO RA; ELLEDGE SJ
      ALTERED CELL-DIFFERENTIATION AND PROLIFERATION IN MICE LACKING P57(KIP2) INDICATES A ROLE IN BECKWITH-WIEDEMANN-SYNDROME

      Nature
    23. KWONG YL; CHEN SH; KOSAI K; FINEGOLD M; WOO SLC
      COMBINATION THERAPY WITH SUICIDE AND CYTOKINE GENES FOR HEPATIC METASTASES OF LUNG-CANCER

      Chest
    24. OVERTURF K; ALDHALIMY M; OU CN; FINEGOLD M; GROMPE M
      SERIAL TRANSPLANTATION REVEALS THE STEM-CELL-LIKE REGENERATIVE POTENTIAL OF ADULT-MOUSE HEPATOCYTES

      The American journal of pathology
    25. HERMAN GE; FEIGENBAUM A; ZHAO W; FINEGOLD M; DEGOUYON B; LAPORTE J; MANDEL JL; METZENBERG A
      MEDICAL COMPLICATIONS IN LONG-TERM SURVIVORS WITH X-LINKED MYOTUBULARMYOPATHY (MTM1)

      American journal of human genetics
    26. MANNING K; ALDHALIMY M; FINEGOLD M; MONTAGUTELLI X; GROMPE M
      INHIBITION OF HOMOGENTISIC ACID OXIDASE AS A TREATMENT FOR A MURINE MODEL OF HT1

      American journal of human genetics
    27. GROMPE M; ALDHALIMY M; OVERTURF K; FINEGOLD M
      LONG-TERM DIETARY AND PHARMACOLOGICAL THERAPY OF MURINE TYROSINEMIA TYPE-I

      American journal of human genetics
    28. OVERTURF K; ALDHALIMY M; FINEGOLD M; GROMPE M
      EX-VIVO HEPATIC GENE-THERAPY CORRECTS A MOUSE MODEL OF HT1 AND PROVIDES A MODEL FOR HEPATIC STEM-CELL DELINEATION

      American journal of human genetics
    29. OVERTURF K; ALDHALIMY M; TANGUAY R; BRANTLY M; OU CN; FINEGOLD M; GROMPE M
      HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I (VOL 12, PG 266, 1996)

      Nature genetics
    30. OVERTURF K; ALDHALIMY M; TANGUAY R; BRANTLY M; OU CN; FINEGOLD M; GROMPE M
      HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Nature genetics
    31. HORNQUIST E; LU XH; ROGERSFANI P; FINEGOLD M; BRINBAUMER L; HARRIMAN GR
      G-ALPHA-I2-DEFICIENT MICE WITH COLITIS EXHIBIT A LOCAL INCREASE IN MEMORY CD4(-CELLS AND PRO-INFLAMMATORY TH1-TYPE CYTOKINES() T)

      The FASEB journal
    32. HARRIMAN GR; BOGUE M; ROGERSFANI P; FINEGOLD M; BRADLEY A; PACHECO S
      IGA DEFICIENT MICE SHOW ALTERED IMMUNOGLOBULIN ISOTYPE EXPRESSION ANDMUCOSAL ANTIBODY-RESPONSES

      The FASEB journal
    33. GROMPE M; OVERTURF K; ALDHALIMY M; FINEGOLD M
      SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTES

      Hepatology
    34. CARUSO M; PHAMNGUYEN K; KWONG YL; XU BS; KOSAI KI; FINEGOLD M; WOO SLC; CHEN SH
      ADENOVIRUS-MEDIATED INTERLEUKIN-12 GENE-THERAPY FOR METASTATIC COLON-CARCINOMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    35. OVERTURF K; ALDHALIMY M; GROMPE M; FINEGOLD M
      SUCCESSFUL TREATMENT OF HEREDITARY TYROSINEMIA TYPE-1 IN A MOUSE MODEL BY HEPATOCELLULAR TRANSPLANTATION AND RETROVIRAL GENE DELIVERY

      Laboratory investigation
    36. HSU SY; LAI RJM; FINEGOLD M; HSUEH AJW
      TARGETED OVEREXPRESSION OF BCL-2 IN OVARIES OF TRANSGENIC MICE LEADS TO DECREASED FOLLICLE APOPTOSIS, ENHANCED FOLLICULOGENESIS, AND INCREASED GERM-CELL TUMORIGENESIS

      Endocrinology
    37. GROMPE M; LINDSTEDT S; ALDHALIMY M; KENNAWAY NG; PAPACONSTANTINOU J; TORRESRAMOS CA; OU CN; FINEGOLD M
      PHARMACOLOGICAL CORRECTION OF NEONATAL LETHAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Nature genetics
    38. SMIT JJA; FINEGOLD M
      MODELS IN PHYSICS - PERCEPTIONS HELD BY FINAL-YEAR PROSPECTIVE PHYSICAL SCIENCE TEACHERS STUDYING AT SOUTH-AFRICAN UNIVERSITIES

      International journal of science education
    39. GROMPE M; ALDHALIMY M; OVERTURF K; OU CN; BURLINGAME T; KANNAWAY NG; LINDSTEDT S; FINEGOLD M
      AN IMPROVED MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-1

      Journal of cellular biochemistry
    40. BOWLES N; KOLODKA TM; FINEGOLD M; MOSS L; WOO SLC
      GENE-THERAPY FOR INSULIN-DEPENDENT DIABETES-MELLITUS BY THE HEPATIC EXPRESSION OF INSULIN

      Journal of cellular biochemistry
    41. BRANDT ML; MOISE KJ; WU Y; SAADE G; WOO S; FINEGOLD M
      INTRACARDIAC DELIVERY OF REPLICATION DEFICIENT ADENOVIRUS IN THE RABBIT FETUS RESULTS IN TRANSFECTION OF FETAL LIVER

      Pediatric research
    42. KOLODKA TM; FINEGOLD M; MOSS L; WOO SLC
      GENE-THERAPY FOR DIABETES-MELLITUS IN RATS BY HEPATIC EXPRESSION OF INSULIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    43. GROMPE M; ALDHALIMY M; OU CN; BURLINGAME T; KENNAWAY N; LINDSTEDT S; FINEGOLD M
      PHARMACOLOGICAL CORRECTION OF LETHAL NEONATAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Laboratory investigation
    44. OVERTURF IK; ALDHALIMY M; FINEGOLD M; GROMPE M
      HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE

      American journal of human genetics
    45. SANDBERG JW; LAU C; JACOMINO M; FINEGOLD M; HENNING SJ
      IMPROVING ACCESS TO INTESTINAL STEM-CELLS AS A STEP TOWARD INTESTINALGENE-TRANSFER

      Human gene therapy
    46. GREENBERG NM; DEMAYO FJ; SHEPPARD PC; BARRIOS R; LEBOVITZ R; FINEGOLD M; ANGELOPOULOU R; DODD JG; DUCKWORTH ML; ROSEN JM; MATUSIK RJ
      THE RAT PROBASIN GENE PROMOTER DIRECTS HORMONALLY AND DEVELOPMENTALLY-REGULATED EXPRESSION OF A HETEROLOGOUS GENE SPECIFICALLY TO THE PROSTATE IN TRANSGENIC MICE

      Molecular endocrinology
    47. KOLODKA TM; FINEGOLD M; KAY MA; WOO SLC
      HEPATIC GENE-THERAPY - EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO RAT HEPATOCYTES (VOL 19, PG 491, 1993)

      Somatic cell and molecular genetics
    48. GROMPE M; ALDHALIMY M; KENNAWAY N; FINEGOLD M; SORIANO P
      CREATION OF A MURINE MODEL OF FUMARYLACETOACTETATE DEFICIENCY

      Journal of cellular biochemistry
    49. BRANDT ML; MOISE KJ; WOO S; PONS L; ECKERT JW; FINEGOLD M; SAADE G; LAU C; RUERKLE C; HENNING SJ
      TRANSDUCTION OF SMALL-BOWEL EPITHELIUM WITH RETROVIRAL MARKER GENES IN FETAL RABBITS BY INTRAUTERINE GASTRIC INJECTION

      Pediatric research
    50. GROMPE M; ALDHALIMY M; KENNAWAY NG; FINEGOLD M; SORIANO P
      CREATION OF A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I

      Pediatric research
    51. KAY MA; LANDEN CN; ROTHENBERG SR; TAYLOR LA; LELAND F; WIEHLE S; FANG BL; BELLINGER D; FINEGOLD M; THOMPSON AR; READ M; BRINKHOUS KM; WOO SLC
      IN-VIVO HEPATIC GENE-THERAPY - COMPLETE ALBEIT TRANSIENT CORRECTION OF FACTOR-IX DEFICIENCY IN HEMOPHILIA-B DOGS

      Proceedings of the National Academy of Sciences of the United Statesof America
    52. GORSKY P; FINEGOLD M
      THE ROLE OF ANOMALY AND OF COGNITIVE-DISSONANCE IN RESTRUCTURING STUDENTS CONCEPTS OF FORCE

      Instructional science
    53. LI QT; KAY MA; FINEGOLD M; STRATFORDPERRICAUDET LD; WOO SLC
      ASSESSMENT OF RECOMBINANT ADENOVIRAL VECTORS FOR HEPATIC GENE-THERAPY

      Human gene therapy
    54. GROMPE M; ALDHALIMY M; FINEGOLD M; OU CN; BURLINGAME T; KENNAWAY NG; SORIANO P
      LOSS OF FUMARYLACETOACETATE HYDROLASE IS RESPONSIBLE FOR THE NEONATALHEPATIC-DYSFUNCTION PHENOTYPE OF LETHAL ALBINO MICE

      Genes & development
    55. KOLODKA TM; FINEGOLD M; WOO SLC
      HEPATIC GENE-THERAPY - EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO RAT HEPATOCYTES IN-VIVO

      Somatic cell and molecular genetics
    56. KAY MA; LI QT; FINEGOLD M; STRATFORDPERRICAUDET LD; WOO SLC
      RECOMBINANT ADENOVIRAL VECTORS FOR HEPATIC GENE-THERAPY

      Journal of cellular biochemistry
    57. ELLIS KJ; SHYPAILO RJ; SCHANLER R; LANGSTON C; FINEGOLD M
      POSTMORTEM ACTIVATION-ANALYSIS - PRELIMINARY-OBSERVATIONS IN THE PRETERM INFANT

      Journal of radioanalytical and nuclear chemistry
    58. KAY MA; ROTHENBERG S; LANDEN CN; BELLINGER DA; LELAND F; TOMAN C; FINEGOLD M; THOMPSON AR; READ MS; BRINKHOUS KM; WOO SLC
      IN-VIVO GENE-THERAPY OF HEMOPHILIA-B - SUSTAINED PARTIAL CORRECTION IN FACTOR-IX-DEFICIENT DOGS

      Science
    59. SANDBERG JW; LAU C; FINEGOLD M; MAJOR AM; HENNING SJ
      INVIVO MODEL OF INTESTINAL MUCUS REMOVAL AND ITS APPLICATION TO INTESTINAL GENE-TRANSFER

      Gastroenterology
    60. GROMPE M; ALDHALIMY M; KENNAWAY N; FINEGOLD M; SORIANO P
      CREATION OF A MOUSE MODEL OF FUMARYLACETOACETATE HYDROLASE DEFICIENCY

      American journal of human genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 05:50:51